Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 is added and an older revision v3.5.0 is removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:56:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T18:19:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and removed the previous entry v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-11T14:44:54.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history. The deletions include a funding notice and the prior revision (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T01:54:38.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A site-wide government funding notice was added and the record revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-03T23:25:34.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    UI improvements include a glossary toggle, color-coded change indicators for additions and deletions, and an updated revision label (v3.4.0).
    Difference
    0.8%
    Check dated 2026-01-27T19:58:51.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.